Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00800
|
|||||
| Drug Name |
Moxifloxacin
|
|||||
| Synonyms |
(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid; 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid; Actira (*Hydrochloride*); Avalox (TN); Avelon (TN); Avelox; Avelox (*Hydrochloride*); Avelox (TN); Avelox I.V.; MFX; MXF; MXFX; Moxifloxacin [INN:BAN]; Vigamox; Vigamox (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H24FN3O4
|
|||||
| Canonical SMILES |
COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
|
|||||
| InChI |
InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1
|
|||||
| InChIKey |
FABPRXSRWADJSP-MEDUHNTESA-N
|
|||||
| CAS Number |
CAS 354812-41-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 401.4 | Topological Polar Surface Area | 82.1 | ||
| Heavy Atom Count | 29 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
0.6
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.